AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Jun 18, 2015
30583_dirs_2015-06-18_5fad6b2c-bd0b-40a0-bf03-fa692f3ab599.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-06-10
Reporting Person: LEWIS ALAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-10 | Common Stock | A | 1100 | — | Acquired | 22500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-10 | Common Stock (right to buy) | $122.27 | A | 3300 | Acquired | 2025-06-09 | Common Stock (3300) | Direct |
Footnotes
F1: This transaction, originally due to be reported on Friday, June 12, 2015, is being reported late due to an administrative oversight.
F2: Restricted stock units granted on June 10, 2015. Price not applicable.
F3: Option grant vests 1/4 on September 10, 2015 and 1/4th every 90 days thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19